neurocare
PrivateLast Round
Early Funding
Feb 5, 2025
Total Funding Raised
$37.11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
neurocare operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was an Early Funding round in February 2025.
neurocare is a healthcare technology company that provides a digital therapy platform to empower clinicians with personalized treatment for mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Vertical SaaS
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neurocare Comparables
Compare neurocare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuronetics Inc | 77% | |
| Magstim | 77% | |
| Wave Neuroscience | 77% |
For institutional investors. Book with your work email.
neurocare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 5, 2025 | ||||
| Series A | Apr 24, 2024 | ||||
| Strategic | Jul 2, 2020 | ||||
| Strategic | Jul 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
neurocare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| re.Mind Capital | Strategic |
| TVM Capital Healthcare | Early Funding, Series A |
| bm|t beteiligungsmanagement thüringen | Strategic, Series A |
| Aescuvest | Series A |
| Impact Expansion | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 37, 8.5x the trailing average.
- Feb 5, 2025
$20.1M raised from TVM Capital Healthcare and Impact Expansion.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 25, 2026
Neurocare Group and Wave Neuroscience, Inc. announce a strategic collaboration on Sep 25th '26 in Germany and Georgia to expand access to complementary neuromodulation solutions and support broader availability of the FDA-cleared MeRT(R) system for patients with PTSD.
For institutional investors. Book with your work email.
neurocare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about neurocare's valuation, stock price, and market status.
Is neurocare a public or private company?
neurocare is a private company.
What is the current stock price of neurocare?
neurocare is a private company, so its shares have no public market price. Caplight tracks neurocare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is neurocare worth (valuation)?
Valuation information for neurocare is not publicly available.
Can I buy neurocare stock?
neurocare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was neurocare's last funding round?
neurocare's most recent funding round was Early Funding on February 5, 2025.
Who are the main investors in neurocare?
Key investors in neurocare include TVM Capital Healthcare, bm|t beteiligungsmanagement thüringen.
Will neurocare IPO soon?
No public IPO plans have been announced for neurocare.
How can I track neurocare secondary market activity?
Caplight tracks bids, offers, and trades in neurocare's shares on secondary markets.